Teva Pharmaceutical Industries Limited American Depositary Shares(TEVA)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$34.55
52-Week Range
$14.99 – $37.34
YTD
+11.63%
IV Rank (30D)
5.64
Straddle Price
$2.83
P/C Vol Ratio
1.14
Market Cap
$40.3B
Fair Value
+22.8% vs price
Confidence: 70% Alpha Score: 0.30

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.53%
Beta vs SPY1.00
Cost of Equity (CAPM)10.03% (VRP-adj)
WACC8.44%
Volatility Risk Premium+18.5pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+21.1%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.10 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$1.2B
Return on Equity (TTM)19.0%
Book / Price19.7%
Gross Margin (TTM)51.8%
FCF Margin (TTM)6.8%
Debt / Equity1.89
Quality Score3/6 — normal (10y DCF)
Market-Implied Growth+18.3% (reverse-DCF on current price)
SMA 50$33.32 (Market Anchor value)
SMA 20 / Bollinger Mid$34.21
Bollinger Width / SMA2021.3% (drives anchor stability)
Net Debt$11.4B
Market Cap$40B
Peers used for multiples: ABBV, BMY, ESLT, JNJ, LLY, MRK, PFE, ZTS
Blended Fair Value
$42.54
Current Price
$34.63
Deviation
+22.8%
Forward-Return Rank LONG gates ✓
?
Horizon Expected α z Pred Blended z Rank % Active?
21d -8.0% -1.58 -0.63 5.2%
42d -11.2% -1.59 -0.64 4.5%
63d -8.9% -0.77 -0.23 12.8%
Expected α = forward-return point estimate vs SPY (e.g., +7.5% means the predictor expects this stock to outperform SPY by 7.5% over that horizon). For SHORT direction the model uses a different ranking metric (conviction-weighted deviation, not the LGBM prediction); Expected α is shown for reference. flags rows where Expected α disagrees with the FV direction — two independent signals are in conflict; conviction is low even if rank looks extreme.
Forward-Return Rank. A proprietary ensemble of a machine-learning forward-return model and a conviction-weighted fundamental score, ranked cross-sectionally each day across the S&P 500 (and broader universes on the screener). Each stock is scored at three horizons (21/42/63 trading days). "Active" = top/bottom 5% AND all risk filters pass. Backtested mean alpha vs SPY on active picks: 21d LONG +13.4%, 63d +34.9% (S&P 500, walk-forward). Past performance is not indicative of future results.
Value vs momentum conflict ⚠. The "FV direction" (long/short) comes from the fundamentals-based engine — price vs intrinsic value. The "Expected α" comes from a separate machine-learning predictor trained on ~12 features (sector, options-implied move, beta, institutional flow, etc.). Sometimes the two disagree: a stock is overvalued by fundamentals but the predictor expects it to keep outperforming (sector or momentum tailwinds). When all 3 horizons disagree, treat the direction signal as low-conviction — neither model is strongly recommending a position.
MethodImplied PriceWeightDetail
DCF $42.08 24%
DDM (Gordon) n/a 0%
Peer P/E $36.02 11% median 27.3× · 7 peers
Peer EV/EBITDA $65.41 11% median 16.1× · 7 peers
Peer P/B $45.91 2% median 6.7× · 6 peers
Peer P/S $73.04 7% median 4.5× · 7 peers
Market Anchor (SMA50) $33.32 21% stability 43% (BB-width)
Options Expected (B-L 30d) $34.17 24% 20 strikes · skew -1.01
As of 2026-06-12 · updated 2026-06-12 20:59:55.687000
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNYS
Market Cap
$40.3B

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distribut…

Price History
Seasonality
MonthAvg ReturnYears of Data
Jan +2.74% 6
Feb -3.65% 6
Mar -2.99% 6
Apr -0.19% 6
May +3.51% 6
Jun -4.22% 6
Jul +6.25% 5
Aug +3.58% 5
Sep -1.71% 5
Oct -1.06% 5
Nov +3.44% 5
Dec +10.52% 5
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $34.18
SMA 50: $33.41
SMA 200: $28.47
Current: $34.63
EMA 12: $34.20
EMA 26: $34.09
MACD: 0.1046 | Signal: -0.0552
BULLISH
ADX (14): 12.36
RANGE
+DI: 23.39
−DI: 21.44
Momentum Oscillators
RSI (14): 53.45
NEUTRAL
Stoch %K: 60.86
Stoch %D: 54.91
Williams %R: -27.10
Volume & Volatility
BB Upper: $35.34
BB Lower: $33.02
NEUTRAL
OBV: 357,537,964
Vol SMA 20: 6,016,886
Vol ROC: -64.82%
ATR: $1.15
True Range: $1.00
HV 20: 36.6%
HV 30: 31.8%
HV 60: 39.1%

Data Summary
Data Points: 500
Last Updated: 2026-06-13T13:41:49.341000
Date Range: 2024-06-14T00:00:00 – 2026-06-12T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

Earnings History
6 of 8 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-07-31 Pre-Market 9.88% 4.82% 0.49x Within
2024-11-06 Pre-Market 7.88% 6.62% 0.84x Within
2025-01-29 Pre-Market 7.48% 13.89% 1.86x Exceeded
2025-05-07 Pre-Market 9.18% 7.97% 0.87x Within
2025-07-30 Pre-Market 8.24% 1.76% 0.21x Within
2025-11-05 Pre-Market 6.99% 20.09% 2.87x Exceeded
2026-01-28 Pre-Market 6.92% 2.43% 0.35x Within
2026-04-29 Pre-Market 12.18% 11.95% 0.98x Within
Options Activity
IV Rank (30D)
5.64
IV Rank (7D)
96.63
Avg IV
48.2%
Straddle (30D)
$2.83
Straddle (7D)
$1.33
P/C Volume
1.14
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Volatility Surface

Enter a ticker to render the implied volatility surface.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
1.00
Correlation (SPY)
31.6%
0.10
Ann. Volatility
39.1%
SPY Volatility
12.3%

Moderate volatility - stock generally follows market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
Diluted shares outstanding: 1,161,750,000 (as of 2025-12-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

662 filers678,245,419 shares$17.00B value58.38% of float
# Filer Shares Value % of Total % of Float Period
1 BlackRock, Inc. Custodian 65,136,464 $1.96B 11.54% 5.61% 2026-03-31
2 Phoenix Financial Ltd. 41,087,131 $1.28B 7.54% 3.54% 2025-12-31
3 MENORA MIVTACHIM HOLDINGS LTD. 39,626,383 $1.19B 7.02% 3.41% 2026-03-31
4 WCM INVESTMENT MANAGEMENT, LLC 40,820,600 $1.16B 6.81% 3.51% 2026-03-31
5 Migdal Insurance & Financial Holdings Ltd. 37,902,212 $1.14B 6.72% 3.26% 2026-03-31
6 FMR LLC Custodian 33,132,795 $997.96M 5.87% 2.85% 2026-03-31
7 Lingotto Investment Management LLP 27,770,857 $836.46M 4.92% 2.39% 2026-03-31
8 STATE STREET CORP 17,790,020 $535.84M 3.15% 1.53% 2026-03-31
9 Rubric Capital Management LP 15,250,000 $459.33M 2.70% 1.31% 2026-03-31
10 Altshuler Shaham Ltd 11,463,621 $334.64M 1.97% 0.99% 2026-03-31
11 GEODE CAPITAL MANAGEMENT, LLC Custodian 10,564,988 $316.25M 1.86% 0.91% 2026-03-31
12 Capital World Investors 8,833,566 $266.07M 1.57% 0.76% 2026-03-31
13 MORGAN STANLEY Custodian 8,444,801 $263.56M 1.55% 0.73% 2025-12-31
14 NORTHERN TRUST CORP Custodian 7,635,688 $229.99M 1.35% 0.66% 2026-03-31
15 WELLINGTON MANAGEMENT GROUP LLP Custodian 7,251,828 $218.43M 1.29% 0.62% 2026-03-31
16 GLENVIEW CAPITAL MANAGEMENT, LLC 6,660,220 $200.61M 1.18% 0.57% 2026-03-31
17 JPMORGAN CHASE & CO Custodian 6,762,744 $191.72M 1.13% 0.58% 2026-03-31
18 Alyeska Investment Group, L.P. 5,519,030 $166.23M 0.98% 0.48% 2026-03-31
19 Polar Capital Holdings Plc 5,175,058 $155.87M 0.92% 0.45% 2026-03-31
20 GOLDMAN SACHS GROUP INC Custodian 4,826,245 $145.37M 0.86% 0.42% 2026-03-31
21 JANUS HENDERSON GROUP PLC 4,816,657 $145.08M 0.85% 0.41% 2026-03-31
22 SCHRODER INVESTMENT MANAGEMENT GROUP 4,376,270 $131.81M 0.78% 0.38% 2026-03-31
23 Swiss National Bank 4,227,900 $127.34M 0.75% 0.36% 2026-03-31
24 BANK OF AMERICA CORP /DE/ Custodian 3,958,814 $119.24M 0.70% 0.34% 2026-03-31
25 SOUND SHORE MANAGEMENT INC /CT/ 3,885,683 $117.04M 0.69% 0.33% 2026-03-31
32 filers$660.89M notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $219.99M 33.29% 2026-03-31
2 Walleye Trading LLC $77.32M 11.70% 2026-03-31
3 CITADEL ADVISORS LLC Custodian $58.20M 8.81% 2026-03-31
4 Nantahala Capital Management, LLC $45.18M 6.84% 2026-03-31
5 JANE STREET GROUP, LLC Custodian $34.89M 5.28% 2026-03-31
6 Caption Management, LLC $32.82M 4.97% 2026-03-31
7 PICTON MAHONEY ASSET MANAGEMENT $30.12M 4.56% 2026-03-31
8 UBS Group AG Custodian $25.41M 3.84% 2026-03-31
9 SIMPLEX TRADING, LLC Custodian $19.37M 2.93% 2026-03-31
10 MILLENNIUM MANAGEMENT LLC Custodian $18.20M 2.75% 2026-03-31
11 NOMURA HOLDINGS INC $16.72M 2.53% 2026-03-31
12 GROUP ONE TRADING LLC Custodian $16.52M 2.50% 2026-03-31
13 Squarepoint Ops LLC $16.02M 2.42% 2026-03-31
14 IMC-Chicago, LLC Custodian $13.73M 2.08% 2026-03-31
15 CAPITAL FUND MANAGEMENT S.A. $6.48M 0.98% 2026-03-31
16 HIGHLAND PEAK CAPITAL, LLC $6.02M 0.91% 2026-03-31
17 Walleye Capital LLC $4.47M 0.68% 2026-03-31
18 WOLVERINE TRADING, LLC Custodian $4.15M 0.63% 2025-09-30
19 TUDOR INVESTMENT CORP ET AL $3.82M 0.58% 2026-03-31
20 Centiva Capital, LP $3.77M 0.57% 2026-03-31
21 Point72 Asset Management, L.P. $2.36M 0.36% 2026-03-31
22 JPMORGAN CHASE & CO Custodian $1.55M 0.23% 2026-03-31
23 Altshuler Shaham Ltd $1.26M 0.19% 2026-03-31
24 BOOTHBAY FUND MANAGEMENT, LLC $1.26M 0.19% 2026-03-31
25 PEAK6 LLC $608.42K 0.09% 2026-03-31
26 filers$384.01M notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $155.18M 40.41% 2026-03-31
2 Walleye Trading LLC $63.52M 16.54% 2026-03-31
3 CITADEL ADVISORS LLC Custodian $38.42M 10.00% 2026-03-31
4 JANE STREET GROUP, LLC Custodian $22.25M 5.79% 2026-03-31
5 Caption Management, LLC $20.32M 5.29% 2026-03-31
6 Squarepoint Ops LLC $15.13M 3.94% 2026-03-31
7 Point72 Asset Management, L.P. $11.55M 3.01% 2026-03-31
8 SIMPLEX TRADING, LLC Custodian $9.97M 2.60% 2026-03-31
9 IMC-Chicago, LLC Custodian $8.23M 2.14% 2026-03-31
10 TUDOR INVESTMENT CORP ET AL $7.03M 1.83% 2026-03-31
11 NATIONAL BANK OF CANADA /FI/ Custodian $6.02M 1.57% 2026-03-31
12 GROUP ONE TRADING LLC Custodian $5.30M 1.38% 2026-03-31
13 WOLVERINE TRADING, LLC Custodian $4.17M 1.09% 2025-09-30
14 CAPITAL FUND MANAGEMENT S.A. $3.43M 0.89% 2026-03-31
15 PEAK6 LLC $3.01M 0.78% 2026-03-31
16 UBS Group AG Custodian $2.71M 0.71% 2026-03-31
17 Crawford Fund Management, LLC $2.20M 0.57% 2026-03-31
18 Walleye Capital LLC $1.80M 0.47% 2026-03-31
19 Verition Fund Management LLC $1.54M 0.40% 2026-03-31
20 JPMORGAN CHASE & CO Custodian $1.42M 0.37% 2026-03-31
21 MILLENNIUM MANAGEMENT LLC Custodian $475.90K 0.12% 2026-03-31
22 SUMMIT SECURITIES GROUP LLC $301.20K 0.08% 2026-03-31
23 Capital Markets Trading UK LLP $22.79K <0.01% 2026-03-31
24 CMT Capital Markets Trading GmbH $6.87K <0.01% 2026-03-31
25 WOLVERINE ASSET MANAGEMENT LLC $3.01K <0.01% 2026-03-31
Insider Activity
Latest: 2026-06-08
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-06-08 Tal Zvi Zaks Director Exer (M) +14,492 EDGAR
2026-06-08 Richard D Francis President and CEO Mixed +6,890 $34.35 -$211.4K EDGAR
2026-06-08 Perry Nisen Director Exer (M) +14,492 EDGAR
2026-06-08 Chen Lichtenstein Director Exer (M) +14,492 EDGAR
2026-06-08 Ronit Satchi-Fainaro Director Exer (M) +14,492 EDGAR
2026-06-08 Amir Elstein Director Exer (M) +14,492 EDGAR
2026-06-08 Rosemary A Crane Director Exer (M) +14,492 EDGAR
2026-06-08 ROBERTO MIGNONE Director Exer (M) +14,492 EDGAR
2026-06-08 SOL J BARER Director Exer (M) +21,739 EDGAR
2026-06-08 GERALD M LIEBERMAN Director Exer (M) +14,492 EDGAR
2026-06-04 Matthew Shields EVP, Global Operations Mixed $32.87 -$532.3K EDGAR
2026-06-01 SOL J BARER Director Grant (A) +10,863 RSU EDGAR
2026-06-01 Amir Elstein Director Grant (A) +7,242 RSU EDGAR
2026-06-01 Ronit Satchi-Fainaro Director Grant (A) +7,242 RSU EDGAR
2026-06-01 Perry Nisen Director Grant (A) +7,242 RSU EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
40 insiders · @ $34.63
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Amir Elstein Director 2,118,455 $73.36M $0 19 2026-06-08
2 Kare Schultz President and CEO 1,542,471 $53.42M $0 15 2022-11-02
3 Richard D Francis President and CEO 1,177,529 $40.78M -$34.82M 15 2026-06-08
4 ROBERTO MIGNONE Director 487,407 $16.88M -$9.16M 23 2026-06-08
5 SOL J BARER Director 448,011 $15.51M $2.00M 22 2026-06-08
6 Dan S Suesskind Director 318,836 $11.04M $0 1 2018-01-23
7 Eliyahu Sharon Kalif EVP, Chief Financial Officer 172,184 $5.96M -$20.90M 29 2026-05-18
8 Sven Dethlefs EVP, North America Commercial 165,381 $5.73M -$2.11M 26 2023-03-08
9 Eric Drape Executive VP Global Operations 145,915 $5.05M -$4.46M 23 2024-03-07
10 GERALD M LIEBERMAN Director 130,149 $4.51M $0 19 2026-06-08
11 Rosemary A Crane Director 127,739 $4.42M -$34.0K 19 2026-06-08
12 Perry Nisen Director 119,807 $4.15M $0 17 2026-06-08
13 Eric A Hughes See "Remarks" 117,244 $4.06M -$6.60M 14 2026-03-09
14 Ronit Satchi-Fainaro Director 112,401 $3.89M $0 16 2026-06-08
15 Dov Bergwerk Acting Chief Legal Officer 96,983 $3.36M $0 2 2024-03-01
16 Mark Sabag See "Remarks" 80,760 $2.80M -$25.95M 38 2026-05-04
17 Evan Lippman EVP, Business Development 80,103 $2.77M -$1.48M 3 2026-05-18
18 Janet S. Vergis Director 73,697 $2.55M $0 10 2025-06-09
19 Tal Zvi Zaks Director 73,264 $2.54M $0 10 2026-06-08
20 Jean Michel Halfon Director 63,707 $2.21M $0 12 2022-08-08
21 Christine Fox EVP, U.S. Commercial 63,647 $2.20M -$3.17M 10 2026-05-04
22 Nechemia Jacob Peres Director 58,765 $2.04M $0 10 2022-08-08
23 Richard Daniell EVP, Europe Commercial 55,755 $1.93M -$23.68M 43 2026-05-07
24 David Matthew Stark Exec. VP Chief Legal Officer 52,449 $1.82M -$4.35M 25 2023-03-08
25 Galia Inbar See "Remarks" 40,301 $1.40M $0 4 2023-03-07
26 Brendan P. O'Grady EVP, North America Commercial 33,773 $1.17M -$1.64M 18 2021-03-08
27 Carlo de Notaristefani Executive VP Global Operations 33,588 $1.16M -$337.4K 6 2019-05-21
28 Eli Shani EVP,Global Marketing&Portfolio 28,225 $977.4K -$43.2K 5 2023-03-07
29 Matthew Shields EVP, Global Operations 26,184 $906.8K -$1.19M 6 2026-06-04
30 Varda Shalev Director 22,504 $779.3K $0 4 2025-06-09
31 Amir Weiss Chief Accounting Officer 20,016 $693.2K -$1.94M 20 2026-05-07
32 Chen Lichtenstein Director 19,296 $668.2K $0 5 2026-06-08
33 Iris Beck Codner EVP Global Brand&Communication 17,996 $623.2K -$94.5K 5 2019-03-06
34 Michael James McClellan EVP, Chief Financial Officer 16,140 $558.9K -$36.1K 9 2019-11-06
35 David R. McAvoy EVP, Chief Legal Officer 13,027 $451.1K -$55.3K 4 2025-09-09
36 Angus Grant EVP, Business Development 12,913 $447.2K -$70.2K 3 2024-08-13
37 Brian Savage Interim Chief Legal Officer 12,041 $417.0K -$163.8K 3 2026-03-09
38 Placid Jover See "Remarks" 6,774 $234.6K -$539.9K 5 2026-03-09
39 Hafrun Fridriksdottir Executive VP, Global R&D 1,386 $48.0K -$3.67M 27 2022-05-19
40 Deborah A Griffin Chief Accounting Officer 944 $32.7K -$333.4K 14 2020-03-19
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/E Ratio28.8
P/B Ratio4.9
P/S Ratio2.3
EV/EBITDA10.7
TTM Revenue$17.3B
TTM Net Income$1.4B
TTM EPS$1.2
ROE19.0%
Debt/Equity2.02